Ferring Pharmaceuticals Articles
Lower risk of CV Events or deaths in prostate cancer patients treated with degarelix compared to LHRH agonists
18 March 2013
Forest in patent settlement with Glenmark; Watson generic Lysteda cleared; and Dr Reddy's debuts generic Propecia
3 January 2013
India's Macleods Pharma to invest $25 million in production in Russia; Ferring to start manufacturing
14 December 2012
Ferring acquires Lysteda from Xanodyne, which aims to focus on pain sector; second deal for the firms
11 May 2010
Stiefel and Ferring named in advertisements for breaches of the ABPI Code of Practice
21 December 2009
Ferring present OA drug results at AAOS
19 May 2009
Ferring initiates prostate cancer trial
30 April 2009
Ferring promotes Paul Korner to SVP of FIPCUS
23 March 2009
Ferring launches degarelix in USA
9 March 2009
Ferring gets EC nod for testosterone blocker
2 March 2009
Ferring creates new exec board led by Michael Pettigrew
23 February 2009
Ferring receives FDA approval for degarelix
12 January 2009
FDA approves Ferring's cancer castration drug
12 January 2009
Ferring's Firmagon OKed by CHMP
12 January 2009
Ferring and Conaris enter deal to develop IBD drug
22 December 2008
Ferring drug better in knee OA than IA-saline
20 October 2008
Ferring appoints Paul Korner VP medical affairs
15 September 2008
Ferring files degarelix as prostate cancer therapy
10 March 2008
Ferring completes degarelix Ph III study
10 December 2007
Euflexxa "cost-effective" at extending QALYs
19 November 2007
Cosmo licenses Budesonide MMX to Ferring
15 October 2007
Ferring's Endometrin approved in USA
2 July 2007
Ferring's Endometrin effective in IVF trial
30 April 2007
Menopur more effective than rFSH in IVF
26 June 2006
Degralix shows promise for prostate cancer
17 April 2006
Ferring Pharma promotes Aaron Graff
3 April 2006
Patarick O'Connor joins Celtic Pharma as MD
5 December 2005
Ferring debuts new fertility treatment in USA
18 April 2005
Arena announces Ferring collaboration
3 June 2002
Ferring gets US OK for infertility drug
13 May 2002
New plant for Ferring in India
13 July 2000
Pharmagene plans London flotation
30 June 2000
38.5% Profits Growth At Galen Holdings
12 November 1998
Proposed Galen/ Ferring Merger Off
13 October 1998
Galen And Ferring Plan L1.5 Billion Merger
24 June 1998
Ferring Successful In Repronex Appeal
14 August 1997
Showing 1-46 of 46 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
